In support of this, increased MEF2B expression was shown to be associated with several B-cell malignancies, including diffuse large B-cell lymphoma (DLBCL), a frequently EBV infected B-cell neoplasm [88]. This evidence concerns the gene MEF2B and diffuse large B-cell lymphoma.